<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref057">
 <label>57</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Boeree</surname>
   <given-names>MJ</given-names>
  </name>, 
  <name>
   <surname>Diacon</surname>
   <given-names>AH</given-names>
  </name>, 
  <name>
   <surname>Dawson</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Narunsky</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>du Bois</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Venter</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis</article-title>. 
  <source>Am J Respir Crit Care Med</source>. 
  <year>2015</year>;
  <volume>191</volume>(
  <issue>9</issue>):
  <fpage>1058</fpage>â€“
  <lpage>65</lpage>. 
  <pub-id pub-id-type="doi">10.1164/rccm.201407-1264OC</pub-id> .
  <?supplied-pmid 25654354?>
  <pub-id pub-id-type="pmid">25654354</pub-id>
 </mixed-citation>
</ref>
